An evaluation of linezolid-associated serotonin toxicity in combination with serotonergic agents at a community teaching hospital
American Journal of Health-System Pharmacy · 2026
DOI: 10.1093/ajhp/zxaf358 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Health-System Pharmacy, 2026. Verfasst von Christopher Donaldson und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical University of South Carolina Health - Orangeburg, Orangeburg, SC, USA. Hauptthemen laut MEDLINE: Linezolid, Hospitals, Teaching, Serotonin Syndrome, Serotonin Agents.
Abstract (Originalsprache)
Purpose
The purpose of this study was to assess demographic and clinical characteristics and potential risk factors for linezolid-associated serotonin toxicity in patients receiving linezolid and concomitant serotonergic agents.
Methods
This was a single-center, retrospective, single-cohort study. Adults at least 18 years of age who were ordered linezolid from January 1, 2014, through October 31, 2023, were screened for inclusion. Patients were included if they received at least one dose of linezolid and a concomitant serotonergic agent. Patients were excluded if the medications were administered more than 24 hours apart or if the patient was pregnant or lactating. All concomitant serotonergic agents were assessed and assigned a dose category based on typical dosing ranges for FDA-approved indications. Serotonin toxicity was assessed utilizing data from the electronic medical record and was defined according to the Sternbach or Hunter criteria.
Results
Of the 615 patients screened, 227 adults met the inclusion criteria with administration of linezolid and a concomitant serotonergic agent. The mean age was 62.4 years, and the mean duration of linezolid treatment was 5.5 days. Most patients were administered only one concomitant medication (59.9%), and most were classified as receiving a low dose (69.1%). Only 2 patients (0.0%) were identified with possible serotonin toxicity as defined by the Sternbach or Hunter criteria, with one case possibly associated with linezolid.
Conclusion
The incidence of serotonin toxicity in hospitalized patients receiving linezolid with concomitant serotonergic agents was low in our study. Linezolid is likely safe in patients receiving select concomitant agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical University of South Carolina Health - Orangeburg, Orangeburg, SC, USA.
- The Brooklyn Hospital Center, Brooklyn, NY, USA.
- Touro College of Pharmacy, New York, NY, and The Brooklyn Hospital Center, Brooklyn, NY, USA.
Zitieren
APA
Donaldson, C., Cerenzio, J., & Andrade, J. (2026). An evaluation of linezolid-associated serotonin toxicity in combination with serotonergic agents at a community teaching hospital. American Journal of Health-System Pharmacy. https://doi.org/10.1093/ajhp/zxaf358
Vancouver
Donaldson C, Cerenzio J, Andrade J. An evaluation of linezolid-associated serotonin toxicity in combination with serotonergic agents at a community teaching hospital. American Journal of Health-System Pharmacy. 2026. doi:10.1093/ajhp/zxaf358
BibTeX
@article{Donaldson2026,
author = {Donaldson, Christopher and Cerenzio, John and Andrade, Justin},
title = {An evaluation of linezolid-associated serotonin toxicity in combination with serotonergic agents at a community teaching hospital},
journal = {American Journal of Health-System Pharmacy},
year = {2026},
doi = {10.1093/ajhp/zxaf358}
}
EUVIMED